SANUWAVE Health Statistics
Total Valuation
SANUWAVE Health has a market cap or net worth of $15.66 million. The enterprise value is $28.69 million.
| Market Cap | 15.66M |
| Enterprise Value | 28.69M |
Important Dates
The last earnings date was Tuesday, November 10, 2026, after market close.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SANUWAVE Health has 8.60 million shares outstanding. The number of shares has increased by 5.22% in one year.
| Current Share Class | 8.60M |
| Shares Outstanding | 8.60M |
| Shares Change (YoY) | +5.22% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 4.91% |
| Owned by Institutions (%) | 23.82% |
| Float | 6.19M |
Valuation Ratios
The trailing PE ratio is 10.79.
| PE Ratio | 10.79 |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| Forward PS | 0.95 |
| PB Ratio | 5.49 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.02 |
| P/OCF Ratio | 4.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.78, with an EV/FCF ratio of 11.03.
| EV / Earnings | 8.16 |
| EV / Sales | 0.70 |
| EV / EBITDA | 15.78 |
| EV / EBIT | 54.14 |
| EV / FCF | 11.03 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 6.88.
| Current Ratio | 1.18 |
| Quick Ratio | 0.70 |
| Debt / Equity | 6.88 |
| Debt / EBITDA | 9.19 |
| Debt / FCF | 7.54 |
| Interest Coverage | 0.26 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 0.97% |
| Return on Invested Capital (ROIC) | 3.38% |
| Return on Capital Employed (ROCE) | 3.29% |
| Weighted Average Cost of Capital (WACC) | 10.97% |
| Revenue Per Employee | $748,182 |
| Profits Per Employee | $63,964 |
| Employee Count | 55 |
| Asset Turnover | 1.21 |
| Inventory Turnover | 1.45 |
Taxes
In the past 12 months, SANUWAVE Health has paid $155,000 in taxes.
| Income Tax | 155,000 |
| Effective Tax Rate | 4.22% |
Stock Price Statistics
The stock price has decreased by -94.54% in the last 52 weeks. The beta is 1.48, so SANUWAVE Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.48 |
| 52-Week Price Change | -94.54% |
| 50-Day Moving Average | 4.51 |
| 200-Day Moving Average | 12.29 |
| Relative Strength Index (RSI) | 25.91 |
| Average Volume (20 Days) | 129,799 |
Short Selling Information
The latest short interest is 180,212, so 2.09% of the outstanding shares have been sold short.
| Short Interest | 180,212 |
| Short Previous Month | 236,233 |
| Short % of Shares Out | 2.09% |
| Short % of Float | 2.91% |
| Short Ratio (days to cover) | 4.33 |
Income Statement
In the last 12 months, SANUWAVE Health had revenue of $41.15 million and earned $3.52 million in profits. Earnings per share was $0.17.
| Revenue | 41.15M |
| Gross Profit | 31.31M |
| Operating Income | 530,000 |
| Pretax Income | 3.67M |
| Net Income | 3.52M |
| EBITDA | 1.82M |
| EBIT | 530,000 |
| Earnings Per Share (EPS) | $0.17 |
Balance Sheet
The company has $6.57 million in cash and $19.61 million in debt, with a net cash position of -$13.04 million or -$1.52 per share.
| Cash & Cash Equivalents | 6.57M |
| Total Debt | 19.61M |
| Net Cash | -13.04M |
| Net Cash Per Share | -$1.52 |
| Equity (Book Value) | 2.85M |
| Book Value Per Share | 0.33 |
| Working Capital | 2.91M |
Cash Flow
In the last 12 months, operating cash flow was $3.29 million and capital expenditures -$689,000, giving a free cash flow of $2.60 million.
| Operating Cash Flow | 3.29M |
| Capital Expenditures | -689,000 |
| Depreciation & Amortization | 1.29M |
| Net Borrowing | -6.07M |
| Free Cash Flow | 2.60M |
| FCF Per Share | $0.30 |
Margins
Gross margin is 76.08%, with operating and profit margins of 1.29% and 8.55%.
| Gross Margin | 76.08% |
| Operating Margin | 1.29% |
| Pretax Margin | 8.93% |
| Profit Margin | 8.55% |
| EBITDA Margin | 4.42% |
| EBIT Margin | 1.29% |
| FCF Margin | 6.32% |
Dividends & Yields
SANUWAVE Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -5.22% |
| Shareholder Yield | -5.22% |
| Earnings Yield | 9.27% |
| FCF Yield | 16.61% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on October 18, 2024. It was a reverse split with a ratio of 1:375.
| Last Split Date | Oct 18, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:375 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |